logo
  

Immunogen Inc. (IMGN) Is Heading Lower After Offering Announcement

Immunogen Inc. (IMGN) announced after the bell Wednesday that it intends to sell 13,000,000 shares of its common stock in an underwritten public offering. The stock is now down 0.63 on 73K shares.

Immunogen climbed during the second half of the morning Wednesday and ended the day with a gain of 0.18 at $7.83.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Pharma Stocks by Subscribing to RTT Biotech Investor.

Inflation data from the U.S. garnered maximum attention this week on the economics front, along with the interest rate decision by the European Central Bank. Read our stories to find out how these two key events are set to influence monetary policy in the months ahead. Other main news from the U.S. were the release of the minutes of the latest Fed policy session and the jobless claims data. Elsewhere, the interest rate decision by the Bank of Canada was also in focus.

View More Videos
Follow RTT